[Federal Register Volume 80, Number 222 (Wednesday, November 18, 2015)]
[Notices]
[Pages 72077-72078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29382]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; The National
Physician Survey of Precision Medicine in Cancer Treatment (NCI)
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, the National
Cancer Institute, the National Institutes of Health (NIH) will publish
periodic summaries of proposed projects to be submitted to the Office
of Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited to address one or more of the following points:
(1) Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) The quality, utility, and clarity of the information to be
collected; and (4) Minimize the burden of the collection of information
on those who are to respond, including the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology.
To Submit Comments and For Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Janet S.
de Moor, Ph.D., MPH, Project Officer, Division of Cancer
[[Page 72078]]
Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC
9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or
Email your request, including your address to: [email protected].
Formal requests for additional plans and instruments must be requested
in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: The National Physician Survey of Precision
Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of this study
is to investigate the current practice of precision medicine in cancer
treatment among medical oncologists in the U.S. This is a nationally
representative survey designed to assess oncologists' current and
potential use of genomic testing, to inform the development of
interventions to facilitate optimal use of genomic testing and to
improve patient-physician discussions of the risks, possible benefits,
and uncertainties surrounding the use of these tests. Current knowledge
of this topic is limited as there are no nationally-representative
studies on this topic to date. There are only two non-federal studies
two that have examined physicians' knowledge and attitudes regarding
somatic genetic and genomic testing. The survey will be administered by
mail and web to approximately 1,630 oncology physicians across the U.S.
Non-respondents will be invited to complete a follow-back survey to
share their reasons for not participating. The study findings will
inform NCI of relevant issues and concerns relating to the application
of precision medicine to current and future cancer treatment patterns
and practice. This information will also inform the development of new
funding initiatives to optimize the use of precision medicine in cancer
treatment. Additionally, information collected as part of this survey
will be used to develop physician educational materials to address
barriers to precision medicine in cancer care delivery.
OMB approval is requested for 2 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 261.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Precision Medicine Survey-- Oncology 175 1 20/60 58
Pilot Study. Physicians.
Precision Medicine Survey-- Oncology 600 1 20/60 200
Full Study. Physicians.
Follow-back Survey............ Oncology 40 1 5/60 3
Physicians.
----------------------------------------------------------------------------------------------------------------
Dated: October 28, 2015.
Karla Bailey,
Project Clearance Liaison, NCI, NIH.
[FR Doc. 2015-29382 Filed 11-17-15; 8:45 am]
BILLING CODE 4140-01-P